11.64 -0.10 (-0.87%)
After hours: 4:32PM EDT
Covid vaccine developer Inovio Pharmaceuticals sold off near 30% Monday after the biotech company said the FDA had put its late-stage trials on hold.
The coronavirus pandemic neared a grim new milestone of 1 million deaths on Monday, as new diagnoses in the around the world continue to outpace a slowdown in the rate of fatalities.
The Nasdaq Composite (NASDAQINDEX: ^IXIC) has gone through a correction over the past month, with investors facing an uncertain future. Just about everything Tesla (NASDAQ: TSLA) has touched lately turns to gold, and that was the case for Australian company Piedmont Lithium (NASDAQ: PLL). Unfortunately, the news wasn't as good for Inovio Pharmaceuticals (NASDAQ: INO), which got some bad news that sent its stock sliding.